Telaprevir Open-Label Study in Co-Infected Patients

Summary

The purpose of this study is to collect safety and tolerability data on telaprevir treatment in combination with Peg-IFN-alfa and RBV in patients with HIV/genotype 1 chronic HCV coinfection with severe fibrosis or compensated cirrhosis who are not eligible for enrollment into an ongoing clinical study of telaprevir.

Timeline

Start

2012-06

Primary completion

2014-08

Completion

2014-08

Publications

• Gori A, Doroana M, Chernova O, Rockstroh JK, Banhegyi D, Bergin C, Verucchi G, Liu C, DeMasi R, Hadacek B, Nelson M. Telaprevir-based therapy for treatment of HIV-1 and hepatitis C virus co-infected patients: An early access programme. J Infect. 2015 Dec;71(6):675-82. doi: 10.1016/j.jinf.2015.09.013. Epub 2015 Sep 28.

Drugs

Indications